NASDAQ:GNCA
Delisted
Genocea Biosciences Stock News
$0.0001
+0 (+0%)
At Close: Apr 19, 2023
CERN breakthrough: Ultra-rare decay of God Particle to help unlock secrets of the Universe
06:18pm, Tuesday, 04'th Aug 2020
SCIENTISTS at CERN are one step closer to understanding how the Higgs boson interacts with the Universe, after observing the never-seen-before decay of the so-called God Particle.
ATLAS Space Operations Awarded NASA SBIR Phase II Award to Advance Satellite Constellation Management Scheduling
12:00am, Tuesday, 04'th Aug 2020
ATLAS Space Operations awarded NASA SBIR contract to develop satellite constellation management scheduling tool for commercial & government use.
Wall Street Breakfast: What Moved Markets This Week
01:45pm, Saturday, 01'st Aug 2020
Listen on the go! Subscribe now to receive Wall Street Breakfast by 8:00 a.m. every trading day, and by 10:00 a.m.
AstraZeneca Nirsevimab Data, And Other News: The Good, Bad And Ugly Of Biopharma
01:07pm, Friday, 31'st Jul 2020
AstraZeneca reports positive data for Nirsevimab. RedHill advances COVID-19 program to Phase 2/3.
Genocea to Present Positive Preliminary Clinical Data Evaluating Neoantigen Vaccine GEN-009 in Combination with Checkpoint Inhibitors
11:00am, Thursday, 30'th Jul 2020
Webcast/conference call scheduled today, July 30th at 8:00 a.m. EDTThree of five patients achieved separate RECIST responses after GEN-009 administrationGEN-009 elicited antigen-specific CD4+ and CD8+
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 27)
Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT)
Bio-Rad Laboratories, Inc. Class B Common Stock (NYSE: BIO)...
HC Wainwright Lowers Genocea Biosciences (NASDAQ:GNCA) Price Target to $9.00
05:18am, Monday, 27'th Jul 2020
Genocea Biosciences (NASDAQ:GNCA) had its target price cut by HC Wainwright from $32.00 to $9.00 in a research note released on Thursday morning, The Fly reports. They currently have a buy rating on t
The Week Ahead In Biotech: Spotlight On GW Pharma, Ultragenyx FDA Decisions, Pfizer Earnings
12:00am, Sunday, 26'th Jul 2020
Biotech stocks moved lower in the week ended July 26, as the broader market weakness and sector-specific developments pressured stocks.
Although there were promising updates from...
The Daily Biotech Pulse: Mixed Tidings From Novavax, Radius Health Out-licenses Breast Cancer Drug, 3 IPOs
12:00am, Friday, 24'th Jul 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 23)
Abbott Laboratories (NYSE: ABT)
ABIOMED, Inc. (NASDAQ: ABMD)
Acceleron Pharma Inc (NASDAQ: XLRN)
Aerpio...
Genocea Biosciences, Inc. (GNCA) CEO Chip Clark on Q2 2020 Results - Earnings Call Transcript
12:06pm, Thursday, 23'rd Jul 2020
Genocea Biosciences, Inc. (NASDAQ:GNCA) Q2 2020 Results Conference Call July 23, 2020 08:30 AM ET Company Participants Dan Ferry - IR, LifeSci Advisors Chip Clark - President and CEO Diantha Duvall -
Genocea Provides Second Quarter 2020 Corporate Update
11:00am, Thursday, 23'rd Jul 2020
Upcoming GEN-009 data update planned for July 30th at 8 a.m. EDT Filed IND application for GEN-011 and is working with the FDA to provide additional information Private Placement with Leading Life S
The Daily Biotech Pulse: Midatech Shelves Sale Plan, G1 Therapeutics Out-Licenses, Entera Bio Jumps On Survey Results
12:00am, Thursday, 23'rd Jul 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 22)
ABIOMED, Inc. (NASDAQ: ABMD)
Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE: BIO)
Bio-Rad Laboratories,...
Genocea Announces Private Placement Financing of Up to $80 Million
01:02pm, Wednesday, 22'nd Jul 2020
CAMBRIDGE, Mass., July 22, 2020 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ:GNCA), a biopharmaceutical company developing personalized cancer immunotherapies, today announced that it has ent
Mid-Day Market Update: Crude Oil Down Over 1%; Blink Charging Shares Surge
12:00am, Wednesday, 22'nd Jul 2020
Midway through trading Wednesday, the Dow traded up 0.29% to 26918.98 while the NASDAQ fell 0.10% to 10,669.72. The S&P also rose, gaining 0.14% to 3,261.95.
The U.S. has the...
Genocea Biosciences Provides Clinical Update
12:00pm, Monday, 20'th Jul 2020
CAMBRIDGE, Mass., July 20, 2020 -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, today announced.
